welcome
CNBC

CNBC

Health

Health

From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs

CNBC
Summary
Nutrition label

64% Informative

Eli Lilly Chief Scientific Officer Dan Skovronsky said obesity medicines need to deliver more than just weight loss.

Skovronky said he is most excited about treating more health conditions with GLP-1s and other incretin medicines.

He sees improving ease of use and making more potent drugs as two paths to move the field forward.

VR Score

59

Informative language

55

Neutral language

73

Article tone

semi-formal

Language

English

Language complexity

46

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links